SCHEMBL7300260

SCHEMBL7300260

CCCCc1nc(C#N)c(C(=O)C(C)(C)C)n1Cc1ccc(-c2ccccc2-c2nnnn2C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 4/20 0.54
AGTR1 P30556 3/20 0.54
AGT P01019 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301471 0.95 AGTR1 (0.59) AGTR2AGTR1AGT
SCHEMBL7308556 0.90 AGTR1 (0.54) AGTR2AGTR1AGT
SCHEMBL7300259 0.88 AGTR1 (0.54) AGTR2AGTR1AGT
SCHEMBL1262 0.87 AGTR1 (0.57) AGTR2AGTR1AGT
SCHEMBL7301927 0.86 AGTR1 (0.59) AGTR2AGTR1AGT
SCHEMBL7299364 0.86 AGTR1 (0.53) AGTR2AGTR1AGT
SCHEMBL7308186 0.85 AGTR1 (0.52) AGTR2AGTR1AGT
SCHEMBL498022 0.84 AGTR2 (0.63) AGTR2AGTR1AGT
SCHEMBL7310565 0.84 AGTR1 (0.59) AGTR2AGTR1AGT
SCHEMBL7297194 0.84 AGTR1 (0.52) AGTR2AGTR1AGT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed